{
    "paper_id": "b1760223f473dfc2a2249653a66292a89332b7e4",
    "metadata": {
        "title": "Supplementary Materials IFITM3 directly engages and shuttles incoming virus particles to lysosomes",
        "authors": [
            {
                "first": "Jennifer",
                "middle": [
                    "S"
                ],
                "last": "Spence",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Albert Einstein College of Medicine",
                    "location": {
                        "postCode": "10461",
                        "settlement": "Bronx",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Ruina",
                "middle": [],
                "last": "He",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Chemical Biology and Microbial Pathogenesis",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "\u2020",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hans-Heinrich",
                "middle": [],
                "last": "Hoffmann",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Virology and Infectious Disease",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Tandrila",
                "middle": [],
                "last": "Das",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Chemical Biology and Microbial Pathogenesis",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Emmanuelle",
                "middle": [],
                "last": "Thinon",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Chemical Biology and Microbial Pathogenesis",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Charles",
                "middle": [
                    "M"
                ],
                "last": "Rice",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Virology and Infectious Disease",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Tao",
                "middle": [],
                "last": "Peng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Chemical Biology and Microbial Pathogenesis",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Kartik",
                "middle": [],
                "last": "Chandran",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Albert Einstein College of Medicine",
                    "location": {
                        "postCode": "10461",
                        "settlement": "Bronx",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Howard",
                "middle": [],
                "last": "Hang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Chemical Biology and Microbial Pathogenesis",
                    "institution": "The Rockefeller University",
                    "location": {
                        "postCode": "10065",
                        "settlement": "New York",
                        "region": "NY",
                        "country": "USA"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Supplementary Table 1 | CRISPR/Cas9-induced mutations in IFITM1, 2 and 3 in HeLa and A549 clones. The target genome of IFITM2 and IFITM3 in HeLa clones was verified by gene sequencing. The expression levels of IFITM2/3 in A549 clone and IFITM1 in all clones were verified by WB analysis. (c) Exogenous dextran trafficking in A549 WT and IFITM2/3-KO cells. Cells were treated with 50 \u03bcg/ml dextran-pHrodo-red for 4 h and cultured for another 20 h in fluorophore-free growth medium. Next, cells were treated for 10 min with 100 \u03bcg/ml dextran-Alexa-488 and shifted for 5 min to fluorophore-free growth medium for indicated time periods. (d) Quantification of (c) under 40 min was performed by Image J. 20 cells were randomly picked from each group and the ratio of localization was analyzed under the same threshold. The percentage of merged volume above threshold colocalized was counted by Image J software. The values shown represent the mean and standard deviation (n = 20), as defined by error bars. *P < 0.05 (n = 20), t-test. ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 14,
                    "end": 21,
                    "text": "Table 1",
                    "ref_id": null
                }
            ],
            "section": "Supplementary Tables"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Localization of IFITM3-N21\uf044 in A549 IFITM2/3 KO cells as visualized by anti-CD63 and anti-IFITM3 staining. Scale bar, 5 \u03bcm. (b) Western blot analysis of IFITM1, IFITM2 and IFITM3 in IFN-\u03b1 stimulated A549 WT and IFITM2/3 KO cells. Full gels in Supplementary Figure 18d. (c) Relative IAV infection of IFN-\u03b1 stimulated A549 WT and IFITM2/3-KO cells. Data represent the mean and standard deviation of three independent experiments",
            "authors": [],
            "year": null,
            "venue": "Supplementary Figure 11 | Distribution and antiviral activity of IFITM3-N21\uf044 in A549 IFITM2/3 KO cells. (a)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Supplementary Figure 18 | Full gels for western blots. (a) Supplementary Figure 1d. (b) Supplementary Figure 4b. (c) Supplementary Figure 8b. (d) Supplementary Figure 11b",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Example of DiD-IAV dequenching in a LAMP-GFP-expressing HeLa IFITM2/3-KO cell. The white arrow marks the particle of interest, and the red arrow indicates the onset of dequenching",
            "authors": [],
            "year": null,
            "venue": "M1",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Example of DiD-IAV dequenching following colocalization with IFITM3-F8-BODIPY in a HeLa IFITM2/3-KO cell. The white arrow marks the particle of interest, and the red arrow indicates the onset of dequenching",
            "authors": [],
            "year": null,
            "venue": "M2",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Example of DiD-IAV dequenching prior to colocalization with IFITM3-F8-BODIPY in a HeLa IFITM2/3-KO cell. The white arrow marks the particle of interest, and the red arrow indicates the onset of dequenching",
            "authors": [],
            "year": null,
            "venue": "M3",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Example of LASV GPC-pseudotyped DiD-VSV dequenching following colocalization with IFITM3-F8-BODIPY in a HeLa IFITM2/3-KO cell. The white arrow marks the particle of interest, and the red arrow indicates the onset of dequenching",
            "authors": [],
            "year": null,
            "venue": "M4",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Design and characterization of IFITM2/3-KO cell lines. (a) Expression of IFITM1, 2 and 3 in A549 and HeLa cells is stimulated by type I IFNs. (b) The IFITM3 sgRNA-targeting site is located in exon 1. (c) The detection of gene editing efficiency of sgRNAs by T7E1 assay. HeLa cells were lysed for genome extraction after transfecting with gRNA and Cas9 plasmids for 60-72 h. The sgRNA target sites were amplified and digested by T7 Endonuclease I, then analyzed by gel electrophoresis. (d) Western blot analysis of IFITM3 protein levels in different HeLa cell clones stimulated with IFN-\u03b1 (100 \u03bcg/mL). Full gels in Supplementary Figure 18a. (e) Flow cytometry analysis of IAV infection of different HeLa cell clones. (f and g) Infection with VSV, DENV, YFV, VEEV and ONNV in na\u00efve and IFN-\u03b1\uf020stimulated HeLa and A549 cell lines (WT and KO). A minimum of 50,000 cells were analyzed for each sample. Supplementary Figure 2 | Characterization of late endocytic markers and exogenous cargo trafficking in IFN-\u03b1 stimulated A549 cells. (a) GFP-Rab7a and LAMP1-mCherry distribution in A549 WT and IFITM2/3-KO cells. (b) GFP-Rab5a and LAMP1-mCherry distribution in A549 WT and IFITM2/3-KO cells.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Characterization of endosomal membrane permeability in IFN-\u03b1 stimulated A549 cells. (a) dfTAT 1 uptake, reduction and fluorescence as a measure of endosomal membrane permeability. (b) Epifluorescence microscopy analysis of dfTAT fluorescence after incubation with HeLa cells for indicated time. Scale bar 100 \u03bcm. (c) Analysis of dfTAT uptake and fluorescence by flow cytometry. HeLa WT and IFITM2/3-KO cells were treated with 2 \uf06dM dfTAT for indicated time with or without IFN-\uf061 pretreatment, then lysed for flow cytometry assay.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Cys-Lys( -NH-TMR)-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Analysis of membrane protein turnover and lysosomal protease activity in WT and IFITM2/3 KO cells.(a) Internalization rates of EGFR in IFN-\uf061 stimulated A549 WT and IFITM2/3-KO cells. (b) Expression levels of non-activated (time = 0) and activated TfR in IFN-\uf061 stimulated A549 WT, IFITM2/3-KO and IFITM2/3-KO cells + stable re-expression of IFITM3. Cells were treated with IFN-\u03b1 (100 \u03bcg/mL) for 16 h, treated with 25 \u03bcg/ml cycloheximide and 20 ug/ml Tf in serumfree DMEM media. Cells were then harvested at various time points, frozen and then lysed for Western blot analysis. Full gels inSupplementary Figure 18b. (c) Quantitation of TfR levels in (b) normalized to tubulin. Data represent the mean and standard deviation of three independent experiments. (d) Analysis of Cathepsin B activity using fluorogenic substrate. After IFN-\uf061 treatment for 16 h with or without Bafilomycin A1, cells were incubated with Magic Red (1:26) for 30-60 min at 37\u00b0C. Following two PBS washes, cells were fixed using 4% PFA and analyzed by flow cytometry. (e) Expression and activity profiling of endocytic proteases was based on cathepsin activity-based protein profiling (ABPP) 2 . In vitro analysis of DiD-labeled IAV. Coverslip-bound DiD-labeled IAV costained with a Zenon AlexaFluor 555 (Life Technologies)-conjugated monoclonal antibody against IAV-HA, showing that over 90% of virions exhibit membrane labeling above threshold and that the selfquenched dye can be easily visualized for particle tracking. Scale bar 10 \u03bcm. Distribution of IAV-NP in IFN-\u03b1 stimulated A549 cells. (a) Co-staining of CD63 and IAV-NP in IFN-\u03b1 treated A549 WT cells at 4 h p.i. After IFN-\u03b1 treatment for 16 h, cells were incubated on ice with IAV (MOI = 300) for 40 min. Following virus binding, the media was removed and cultures were shifted to 37\u00b0 C for additional 4 h, then cells were fixed for immunofluorescence. Scale bar, 5 \u03bcm. (b) Structured illumination imaging of IFITM3 and IAV-NP using OMX Blaze 3D-SIM superresolution microscope (Applied Precision). Scale bar, 5 \u03bcm. Expanded image highlight IFITM3 staining around anti-IAV NP staining. Scale bar, 1 \u03bcm. Schematic for site-specific labeling IFITM3 with BODIPY in mammalian cells. Amber suppression-mediated unnatural amino acid mutagenesis enables site-specific labeling of IFITM3-TAG mutants with TCOK, which can then be selectively labeled with BODIPY-Tz and analyzed by fluorescence microscopy to image IFITM3 and virus trafficking in living cells. Schematic for site-specific labeling of IFITM3 with BODIPY in mammalian cells.(a) HEK293 cells were transfected with HA-IRGM1 (negative control), HA-IFITM3 (positive control), or HA-IFITM3-F8TAG + Mm-PylRS-AF/Pyl-tRNA CUA plasmid in the presence of TCOK, and labeled with BODIPY-Tz before infection with IAV (MOI = 2.5) for 6 h. Cells were then harvested and stained with anti-IAV NP-Alexa Fluor 568 and anti-HA-Alexa Fluor 647 for flow cytometry analysis. A minimum of 50,000 cells were analyzed for each sample. (a) Western blot analysis with \uf061-IFITM3 antibody of IFITM2/3-KO cells expressing HA-IFITM3-TCOK compared to WT HeLa + IFN\uf061. (b) Western blot analysis with \uf061-IFITM3 antibody of IFITM2/3-KO cells expressing HA-IFITM3-TCOK compared to WT HeLa + IFN\uf061. Full gels in Supplementary Figure 18c. (c) Flow cytometry analysis with \uf061-IFITM3 antibody of IFITM2/3-KO cells expressing HA-IFITM3-TCOK compared to WT HeLa + IFN\uf061. (d) Immunofluorescence analysis with \uf061-IFITM3 antibody of IFITM2/3-KO cells expressing HA-IFITM3-TCOK compared to WT HeLa + IFN\uf061. HA staining (AF-647) NP staining (AF-568) Localization of HA-IFITM3-F8-BODIPY. Live steady-state epifluorescence imaging of IFITM3-F8-BODIPY with the RFP-tagged endosomal markers Rab5, Rab7, and LAMP1 in HeLa IFITM2/3-KO cells. Scale bar, 10 \u03bcm. Colocalization of IFITM3 with IAV and LASV GPC-VSV in HeLa IFITM2/3 KO cells. (a) Relative percentage of cell-associated IAV particles undergoing lipid mixing in HeLa IFITM2/3-KO cells expressing IFITM3-F8-BODIPY. Data represent the mean and standard deviation of three independent experiments. (b) Colocalization of IAV and LASV GPC-pseudotyped VSV particles with IFITM3+ compartments in HeLa cells at 1 h p.i.. Scale bar, 10 \u03bcm. (c). Relative percentage of cellassociated IAV particles undergoing lipid mixing in HeLa IFITM2/3-KO cells expressing IFITM3-V93-BODIPY or IFITM3-N21\uf044-V93-BODIPY. Data represent the mean and standard deviation of three independent experiments. Localization of IFITM3-N21\uf044 in HeLa IFITM2/3 KO cells. Live steadystate epifluorescence imaging of IFITM3-N21\uf044-V93-BODIPY with the RFP-tagged endosomal markers Rab5, Rab7, and LAMP1 in HeLa IFITM2/3-KO cells. Scale bar, 10 \u03bcm. Confocal fluorescence microscopy. (a) Analysis of WT and N21\uf044-IFITM3 distribution in live cells with plasma membrane marker (Cell Mask). Scale bar, 5 \u03bcm. (b) Quantification of IFITM3 and Cell Mask overlap.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Site-specific S-palmitoylation regulates IFITM3 antiviral activity. (a) Sfatty-acylation of immunoprecipitated WT IFITM3-F8-BocLys and Cys mutants in HeLa IFITM2/3-KO cells using alk-16 metabolic labeling and reaction with az-rho dye for in-gel fluorescence detection. For these experiments, Boc-Lys was used as UAA to prevent cross-reactivity with az-rho dye. Full gels in Supplementary Figure 18e. (b) Quantitation of WT IFITM3-F8-BocLys and Cys mutant S-fatty-acylation using alk-16 labeling in a. Data represent the mean and standard deviation of three independent experiments. (c) Anti-IAV activity of WT IFITM3-F8-Boc-Lys and Cys mutants in HeLa IFITM2/3-KO cells. Data represent the mean and standard deviation of three independent experiments. (d) Time of IAV lipid mixing relative to particle colocalization with WT IFITM3 or the C72A mutant in HeLa IFITM2/3-KO cells (n > 50 dequenching particles tracked in three independent experiments for each sample)Live cell imaging of IFITM3 Cys mutants with endosomal markers in HeLa IFITM2/3 KO cells. Steady-state epifluorescence imaging of (a) IFITM3-F8-BODIPY-C72A, (b) IFITM3-F8-BODIPY-C71A, and (c) IFITM3-F8-BODIPY-C105A with RFP-tagged endosomal markers. Scale bar, 10 \u03bcm. Live cell imaging of additional IFITM3 Cys mutants with DiD-IAV in HeLa IFITM2/3 KO cells. (a) DiD-IAV dequenching in the presence of IFITM3-F8-BODIPY-C71A. Bar, 5 \u03bcm. (b) DiD-IAV dequenching in the presence of IFITM3-F8-BODIPY-C72A. Scale bar, 5 \u03bcm. (c) DiD-IAV dequenching in the presence of IFITM3-F8-BODIPY-C105A. Scale bar,",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}